Fernandez Ruiz, Javier javier.fernandezr@uam.es

Actividades

TIME-COURSE OF THE EFFECTS OF OVARIAN-STEROIDS ON PITUITARY PROLACTIN-RELEASE - LACK OF CORRELATION WITH THE CHANGES IN THE ACTIVITY OF TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS

  • Demiguel, R
  • Fernandezruiz, JJ
  • Hernandez, ML
  • Ramos, JA

NEUROENDOCRINOLOGY LETTERS (p. 67-73) - 1/1/1991

  • ISSN 0172780X
  • iMarina

Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling

  • Moreno E
  • Andradas C
  • Medrano M
  • Caffarel MM
  • Pérez-Gómez E
  • Blasco-Benito S
  • Gómez-Cañas M
  • Pazos MR
  • Irving AJ
  • Lluís C
  • Canela EI
  • Fernández-Ruiz J
  • Guzmán M
  • McCormick PJ
  • Sánchez C
... Ver más Contraer

JOURNAL OF BIOLOGICAL CHEMISTRY (p. 21960-21972) - 8/8/2014

10.1074/jbc.m114.561761 Ver en origen

  • ISSN 00219258

Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders

  • Navarro G
  • Morales P
  • Rodríguez-Cueto C
  • Fernández-Ruiz J
  • Jagerovic N
  • Franco R

Frontiers In Neuroscience - 13/9/2016

10.3389/fnins.2016.00406 Ver en origen

  • ISSN 16624548

Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis

  • Espejo-Porras F
  • García-Toscano L
  • Rodríguez-Cueto C
  • Santos-García I
  • de Lago E
  • Fernandez-Ruiz J

BRITISH JOURNAL OF PHARMACOLOGY (p. 1585-1600) - 1/5/2019

10.1111/bph.14216 Ver en origen

  • ISSN 00071188

Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

  • Rodríguez-Cueto C
  • García-Toscano L
  • Santos-García I
  • Gómez-Almería M
  • Gonzalo-Consuegra C
  • Espejo-Porras F
  • Fernández-Ruiz J
  • de Lago E
... Ver más Contraer

BRITISH JOURNAL OF PHARMACOLOGY (p. 1373-1387) - 1/3/2021

10.1111/bph.15386 Ver en origen

  • ISSN 00071188

Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice

  • Palomo-Garo C
  • Gómez-Gálvez Y
  • García C
  • Fernández-Ruiz J

PHARMACOLOGICAL RESEARCH (p. 181-192) - 1/8/2016

10.1016/j.phrs.2016.04.004 Ver en origen

  • ISSN 10436618

The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain

  • Gómez M
  • Hernández M
  • Fernández-Ruiz J

BRAIN RESEARCH (p. 48-55) - 11/5/2007

10.1016/j.brainres.2007.01.102 Ver en origen

  • ISSN 00068993

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake

  • Romero J
  • De Miguel R
  • Ramos JA
  • Fernández-Ruiz JJ

LIFE SCIENCES (p. 351-363) - 19/12/1997

10.1016/s0024-3205(97)01117-x Ver en origen

  • ISSN 00243205

The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes

  • Fernández-Ruiz J

BRITISH JOURNAL OF PHARMACOLOGY (p. 1370-1383) - 1/5/2019

10.1111/bph.14382 Ver en origen

  • ISSN 00071188

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

  • Del Río C
  • Navarrete C
  • Collado J
  • Bellido M
  • Gómez-Cañas M
  • Pazos M
  • Fernández-Ruiz J
  • Pollastro F
  • Appendino G
  • Calzado M
  • Cantarero I
  • Muñoz E
... Ver más Contraer

Scientific Reports - 18/2/2016

10.1038/srep21703 Ver en origen

  • ISSN 20452322

Este/a investigador/a no tiene libros.

Cannabinoids and the brain: New hopes for new therapies

  • Fernández-Ruiz J
  • Hernández M
  • García-Movellán Y

Cannabinoids (p. 175-218) - 11/8/2014

10.1002/9781118451281.ch6 Ver en origen

Chapter 2: Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System

  • Fernández-Ruiz J
  • Sagredo O
  • De Lago E

RSC Drug Discovery Series (p. 10-47) - 1/1/2021

10.1039/9781839160752-00010 Ver en origen

  • ISSN 20413203

Endocannabinoid-Binding Receptors as Drug Targets

  • Gómez-Cañas M
  • Rodríguez-Cueto C
  • Satta V
  • Hernández-Fisac I
  • Navarro E
  • Fernández-Ruiz J

Methods In Molecular Biology (p. 67-94) - 1/1/2023

10.1007/978-1-0716-2728-0_6 Ver en origen

  • ISSN 10643745

Endocannabinoids and Neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others

  • Fernández-Ruiz J
  • Romero J
  • Ramos J

Handbook of Experimental Pharmacology (p. 233-259) - 29/9/2015

10.1007/978-3-319-20825-1_8 Ver en origen

  • ISSN 01712004

Endocannabinoids and amyotrophic lateral sclerosis

  • de Lago E
  • Moreno-Martet M
  • Espejo-Porras F
  • Fernández-Ruiz J

Cannabinoids in Neurologic and Mental Disease (p. 99-123) - 21/1/2015

10.1016/b978-0-12-417041-4.00005-9 Ver en origen

La protección de menores en la Policía Municipal de Madrid

  • Javier Fernández Ruiz

El derecho a la protección de los niños y niñas en la Comunidad de Madrid (p. 171-180) - 1/1/2010

  • iMarina

Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

  • Fernández-Ruiz J
  • Gómez-Ruiz M
  • García C
  • Hernández M
  • Ramos JA

Methods In Enzymology (p. 175-198) - 1/1/2017

10.1016/bs.mie.2017.06.021 Ver en origen

  • ISSN 00766879

The endocannabinoid system in the physiology and pathology of the basal ganglia

  • Gerdeman G
  • Fernández-Ruiz J

Cannabinoids and the Brain (p. 423-483) - 1/1/2008

10.1007/978-0-387-74349-3_21 Ver en origen

The service of Minors' Guardian Officers in Madrid Municipal Police

  • Javier Fernández Ruiz

Memoria Del Congreso International Sobre Seguridad Ciudadana En La Sociedad Diversa: 19 A 22 De Octubre De 2011 (p. 370-371) - 1/1/2011

  • iMarina

Cannabinoid tolerance and dependence: A review of studies in laboratory animals

  • González S
  • Cebeira M
  • Fernández-Ruiz J

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (p. 300-318) - 1/1/2005

10.1016/j.pbb.2005.01.028 Ver en origen

  • ISSN 00913057

Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

  • López-Rodríguez ML
  • Viso A
  • Ortega-Gutiérrez S
  • Fowler CJ
  • Tiger G
  • De Lago E
  • Fernández-Ruiz J
  • Ramos JA
... Ver más Contraer

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (p. 403-412) - 1/4/2003

10.1016/s0223-5234(03)00045-x Ver en origen

  • ISSN 02235234

Disentangling self-assessment

  • Panadero, E. & Fernández-Ruiz, J

29/8/2018

  • iMarina

Effects of neonatal exposure to methamphetamine: Catecholamine levels in brain areas of the developing rat

  • Gomes-Da-Silva J
  • De Miguel R
  • Fernández-Ruiz J
  • Summavielle T
  • Tavares M

Annals of the New York Academy of Sciences (p. 602-611) - 1/1/2004

10.1196/annals.1316.075 Ver en origen

  • ISSN 00778923

Evaluación del aprendizaje en Educación Secundaria: Concepciones y prácticas

  • Fernández Ruiz, J. & Panadero, E

23/6/2018

  • iMarina

How is assessment implemented in higher education in Spain? An analysis through syllabi

  • Fraile, J., Panadero, E., Fernández-Ruiz, J., Castilla, D., & Ruiz, M

29/8/2018

  • iMarina

Learning Assessment in Secondary Education: Conceptions and practices

  • Fernández Ruiz, J. & Panadero, E

2/7/2018

  • iMarina

Pharmacology, Biochemistry and Behavior: Editorial

  • Fernandez-Ruiz J

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (p. 221-223) - 1/1/2005

10.1016/j.pbb.2005.03.021 Ver en origen

  • ISSN 00913057

Preface: Cannabinoids as new tools for the treatment of neurological disorders

  • Fernández-Ruiz J
  • Guzmán M
  • Ramos J

MOLECULAR NEUROBIOLOGY (p. 1-2) - 1/1/2007

10.1007/s12035-007-8005-9 Ver en origen

  • ISSN 08937648

Prenatal exposure to methamphetamine in the rat: Ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons

  • Gomes-Da-Silva J
  • Pérez-Rosado A
  • De Miguel R
  • Fernández-Ruiz J
  • Silva MC
  • Tavares MA

Annals of the New York Academy of Sciences (p. 68-77) - 1/1/2002

  • ISSN 00778923
  • iMarina

Este/a investigador/a no tiene documentos de trabajo.

Este/a investigador/a no tiene informes técnicos.

Este/a investigador/a no tiene proyectos de investigación.

Este/a investigador/a no tiene tesis dirigidas.

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 18/03/24 23:57